I mean, just really surprised
Hildebrand, P
Phase 3 TRIUMPH-4 (topline) In Lillys topline summary, the most common adverse events included nausea, diarrhoea, constipation and vomiting (typical of incretin-based therapies)
Saxenda puede contribuir a un mayor riesgo de tumores de clulas C de la tiroides, pancreatitis aguda, enfermedad de la vescula biliar, hipoglucemia, lesin renal aguda, efectos secundarios gastrointestinales graves, reacciones de hipersensibilidad, aumento de la frecuencia cardaca, dolor abdominal, reflujo, gases y mareos
NAC (6001,200 mg) and glutathione (2501,000 mg) are generally safe when used appropriately
Not many people six months ago were talking about these drugs regarding ME/CFS, fibromyalgia, long COVID, etc